Sotac Pharmaceuticals Limited (NSE:SOTAC)

India flag India · Delayed Price · Currency is INR
117.00
+5.00 (4.46%)
Apr 17, 2026, 11:54 AM IST
-1.43%
Market Cap 1.29B
Revenue (ttm) 846.72M
Net Income (ttm) 85.60M
Shares Out 11.05M
EPS (ttm) 7.74
PE Ratio 15.12
Forward PE n/a
Dividend 0.10 (0.09%)
Ex-Dividend Date n/a
Volume 4,800
Average Volume 12,780
Open 115.95
Previous Close 112.00
Day's Range 115.95 - 117.00
52-Week Range 100.00 - 152.35
Beta -0.12
RSI 56.02
Earnings Date May 22, 2026

About Sotac Pharmaceuticals

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products. The compan... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2014
Employees 127
Stock Exchange National Stock Exchange of India
Ticker Symbol SOTAC
Full Company Profile

Financial Performance

In fiscal year 2025, Sotac Pharmaceuticals's revenue was 1.00 billion, a decrease of -3.57% compared to the previous year's 1.04 billion. Earnings were 80.27 million, an increase of 87.48%.

Financial Statements

News

There is no news available yet.